OREANDA-NEWS. November 24, 2015. Eli Lilly and Company (NYSE: LLY) today announced it will host a meeting for the investment community, including institutional investors, sell-side analysts, ratings agency representatives, and financial and business media.

The meeting will take place Tuesday, December 8, 2015, from 9:00 a.m. (EST) until approximately 4:00 p.m., at the Four Seasons Hotel in Boston. 

In the meeting, company leaders will provide an overview of Elanco, Lilly's animal health business, and present a comprehensive survey of the company's Alzheimer's disease research program. There will be Q&A opportunities throughout the meeting.

"We look forward to providing details on two key areas of focus for our company, animal health and Alzheimer's disease," said

John C. Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer. "We will review Elanco's strategy and its growth prospects. Since the acquisition of Novartis Animal Health in January, Elanco has emerged as a top-tier animal health company. In addition, investors can expect to learn more about Lilly's broad research efforts aimed at improving the diagnosis and treatment of Alzheimer's disease."

A live webcast of the Lilly investment community meeting, along with presentation slides, will be available through a link on the investor section of Lilly's website at https://investor.lilly.com/. The webcast will be available for replay over the next 12 months.

Media interested in attending in person should contact

Lauren Zierke at (317) 277-6524. Investors interested in attending should contact

Edward Villacorta at (317) 433-1805.